Sitemap

In numbers

Our philosophy

Core values

At a glance

Global network

Careers

Areas of focus

Technology-driven drug discovery

Main products

Pipeline

Around the world

Partnerships

• ABSTRAL^®
• ALLELOCK^®
• CONIEL^®
• Crysvita^®
• ESPO^® / NESP^®
• GRAN^® / Peglasta^® / Neulasta^®
• LEUNASE^®
• LUMICEF^®
• Moventig^®

• Nouriast^®/ Nourianz^®
• ORKEDIA^®
• PecFent^®
• POTELIGEO^®
• Production Technology
• REGPARA^®
• Romiplate^®/ Nplate^®
• SANCUSO^®

CEO message

Materiality

Group Policies

Retain the trust of society

• Quality assurance and a stable supply of products
• Reducing Environmental Impact

Address patient-centric healthcare needs

• Access to Medicines

Management Infrastructure

• Ethics and transparency
• Reinforce risk management

Strengthen human resources and infrastructure to realize life-changing value

• Diversity, Equity & Inclusion
• Talent portfolio
• Digital Transformation

Community Involvement Activities

Promoting Transparency

ESG-related Information

Governance

Financial Data

Reports & Presentations

Investor Calendar

Stock & Rating

Contact Us/Investors

Disclaimer

Disclosure Policy

News Releases

Social Media

Broadcast videos

Image library

Patients

Innovation

Sustainability

People & Culture

Growth

Contact Us

Sitemap

RSS feeds

Terms & Conditions of Use

Privacy Policy

About cookies

Therapeutic Antibodies

The Story of Basic Immunology

POTELLIGENT ^® Website